GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $151,000 | +71.6% | 2,214 | -20.0% | 0.01% | +100.0% |
Q2 2022 | $88,000 | -8.3% | 2,769 | +0.4% | 0.00% | +50.0% |
Q1 2022 | $96,000 | +3.2% | 2,759 | -13.1% | 0.00% | 0.0% |
Q4 2021 | $93,000 | +13.4% | 3,175 | -1.6% | 0.00% | 0.0% |
Q3 2021 | $82,000 | -30.5% | 3,227 | -3.9% | 0.00% | 0.0% |
Q2 2021 | $118,000 | -13.9% | 3,357 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $137,000 | -26.3% | 3,357 | -21.9% | 0.00% | -25.0% |
Q4 2020 | $186,000 | -21.5% | 4,301 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $237,000 | -12.9% | 4,301 | 0.0% | 0.01% | -14.3% |
Q2 2020 | $272,000 | +21.4% | 4,301 | -1.9% | 0.01% | +16.7% |
Q1 2020 | $224,000 | -36.7% | 4,386 | -1.5% | 0.01% | -25.0% |
Q4 2019 | $354,000 | +59.5% | 4,453 | -2.9% | 0.01% | +60.0% |
Q3 2019 | $222,000 | -8.6% | 4,585 | -0.8% | 0.01% | 0.0% |
Q2 2019 | $243,000 | -2.8% | 4,624 | -2.2% | 0.01% | -16.7% |
Q1 2019 | $250,000 | – | 4,730 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
RA Capital Management | 457,142 | $14,779,000 | 1.46% |
VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |